Abstract
The C-terminal 95 kDa fragment of some isoforms of vertebrate agrins is sufficient to induce clustering of acetylcholine receptors but despite two decades of intense agrin research very little is known about the function of the other isoforms and the function of the larger, N-terminal part of agrins that is common to all isoforms. Since the N-terminal part of agrins contains several follistatin-domains, a domain type that is frequently implicated in binding TGFβs, we have explored the interaction of the N-terminal part of rat agrin (Agrin-Nterm) with members of the TGFβ family using surface plasmon resonance spectroscopy and reporter assays. Here we show that agrin binds BMP2, BMP4 and TGFβ1 with relatively high affinity, the KD values of the interactions calculated from SPR experiments fall in the 10−8 M–10−7 M range. In reporter assays Agrin-Nterm inhibited the activities of BMP2 and BMP4, half maximal inhibition being achieved at ∼5×10−7 M. Paradoxically, in the case of TGFβ1 Agrin N-term caused a slight increase in activity in reporter assays. Our finding that agrin binds members of the TGFβ family may have important implications for the role of these growth factors in the regulation of synaptogenesis as well as for the role of agrin isoforms that are unable to induce clustering of acetylcholine receptors. We suggest that binding of these TGFβ family members to agrin may have a dual function: agrin may serve as a reservoir for these growth factors and may also inhibit their growth promoting activity. Based on analysis of the evolutionary history of agrin we suggest that agrin's growth factor binding function is more ancient than its involvement in acetylcholine receptor clustering.
Introduction
The proteoglycan agrin is crucial for development and maintenance of the neuromuscular junction (NMJ) in vertebrates [1], [2] and it may also have synapse-promoting functions in the CNS [3]–[8]. Vertebrate agrins exist in several isoforms that are generated by alternative splicing (Figure 1). Differential transcription of the first exon of the agrin gene results either in a secreted form that binds to the basal lamina via its laminin-binding N-terminal NtA domain or a shorter isoform without the NtA domain that remains attached to the cellular plasma membrane as a type-II transmembrane protein. The type II transmembrane isoform of agrin predominates in the brain, whereas the secreted variant is the predominant form expressed by motoneurons. Secreted agrin is released from the nerve ending of motoneurons into the synaptic cleft of the neuromuscular junction, where it becomes an essential component of the synaptic basal lamina.
The N-terminal part of all forms of vertebrate agrins consist of nine follistatin-related and two laminin EGF-like modules [9], the middle part contains a SEA module [10], and the C-terminal part contains four epidermal growth factor and three laminin globular domains (Figure 1). With the C-terminal laminin G domain motoneuron-derived agrin affects NMJ formation and maintenance by binding to a receptor complex in the muscle membrane consisting of MuSK (muscle-specific kinase) and LRP4 (low-density lipoprotein receptor-related protein 4)[11], [12].
In vertebrates, alternative splicing at a conserved site in the C-terminal part (Figure 1) gives rise to agrin isoforms with significantly different activities in clustering acetylcholine receptors (AChRs). The isoforms expressed by motoneurons contain an insert of 8, 11, or 19 amino acids at this site and are active in AChR clustering, whereas agrin expressed by muscle has no insert at this site and does not cluster AChRs [1], [13]. Recently, the C-terminal Laminin G domain of agrin was found to be instrumental for the activity-dependent promotion of dendritic filopodia on hippocampal neurons, after its activity-dependent proteolytic release from its parent agrin by the neuronal protease neurotrypsin [6]. In contrast with NMJ formation, activity-dependent promotion of dendritic filopodia does not require an insert at the B/z splice site present in this Laminin G domain [6].
Little is known about the function of agrin's N-terminal region. Based on homology with follistatin, we have suggested previously that this region, common to all agrin isoforms, might bind growth factors of the TGFβ family [9]. In the present study we produced and purified a recombinant N-terminal fragment of agrin (Agrin-Nterm) and used it to study its interaction with various members of the TGFβ family with surface plasmon resonance and reporter assays. SPR studies have revealed that Agrin-Nterm has relatively high affinity for BMP2, BMP4 and TGFβ1 and in reporter assays it inhibits the activity of BMP2 and BMP4 but enhances the activity of TGFβ1. Our finding that Agrin-Nterm binds members of the TGFβ family may have important implications for the role of these growth factors in the regulation of synaptogenesis as well as for the role of agrin isoforms that are unable to induce clustering of acetylcholine receptors.
Materials and Methods
Reagents, enzymes, PCR primers, proteins, bacterial strains, cell lines and media
Restriction enzymes, T4 DNA Ligase and Klenow polymerase were New England Biolabs products (Beverly, MA, USA). PCR primers were obtained from Integrated DNA Technologies (Coralville, IA, USA). For amplification reactions we used Taq polymerase from Fermentas (Vilnius, Lithuania) or the proof-reading thermostable polymerase Accuzyme (Bioline, London, UK). DNA purification was performed with Nucleospin Extract PCR purification kit (Macherey-Nagel, Duren, Germany). Escherichia coli JM109 bacterial strain was used for DNA propagation during DNA manipulation steps. Mature human BMP2, BMP4, TGFβ1 and TGF-βsRII (corresponding to the Extracellular domain of TGF-βRII) were purchased from R&D Systems (Wiesbaden, Germany). CM5 sensorchips and the reagents for protein coupling to the chips were from Biacore AB (Uppsala, Sweden). The extracellular domain of human BMPR1A (ECD-BMPR1A) was produced as described in a separate publication (Szláma, Kondás, Trexler and Patthy, manuscript submitted to JBC).
The firefly luciferase kit was from Biotium (Hayward, CA, USA). Mink lung epithelial cells stably transfected with a truncated PAI-1 promoter/firefly luciferase construct (MLEC-clone32) [14] and HepG2-BRA cells stably transfected with the BRE-luc reporter construct [15] were generously provided by Professor Daniel Rifkin (New York University). Culture media DMEM and heat inactivated FBS were obtained from Sigma-Aldrich (St Louis, Mo USA).
Cloning and expression of the N-terminal region of rat agrin
The cDNA segment encoding residues Asp65-Gln865 of rat agrin (Agrin-Nterm) was amplified with the 5′-GCAGATCTGATGTATGCAGGGGAATGTTATGTGG -3′ sense and 5′-GCTCTAGACTGGCAGGGACCAAGACTCTG-3′ antisense primers using rat agrin cDNA (NCBI Reference Sequence: NM_175754.1).
The amplified DNA was digested with BglII and XbaI restriction endonucleases and ligated into Drosophila expression vector pMT/BiP/V5-His A digested with the same enzymes. The ligation mixture was transformed into Escherichia coli JM109 cells and the recombinants were selected on LB medium with 100 mg/ml Ampicillin. Plasmids from transformants were isolated and analysed for the presence of insert. The sequence of the cloned DNA was verified on both strands.
Drosophila melanogaster S2 cells (DGRC Indiana University, Bloomington, IN USA) were transfected with 4 µg pMT/BiP/V5-His A expression plasmid containing the cDNA encoding Agrin-Nterm and 16 µg pCoHygro selection vector using Cellfectin reagent (Invitrogen, Carlsbad, CA USA) according to the protocol recommended by the manufacturer. For selection of stable transfectants, cells were suspended and cultured in Schneider's Drosophila medium (Invitrogen, Carlsbad, CA USA) supplemented with 10% Fetal bovine serum (Sigma-Aldrich,) and 300 µg/ml hygromycin B (Invitrogen, Carlsbad, CA USA). Stably transformed polyclonal lines were established after 5 weeks of selection with hygromycin B. Except for propagation in serum-free medium hygromycin B was always included in the media.
For protein induction stable transfectants were grown in serum free medium (Invitrogen, Carlsbad, CA USA) to a cell density of 2–3×106/ml and protein expression was induced by adding CuSO4 at 400 µmol final concentration. After 1 week of induction the culture was centrifuged, the conditioned medium was harvested and the cells were suspended in fresh induction medium to start another round of induction. Usually three rounds of induction were performed with the same cells. The medium collected from three rounds of induction was dialyzed against 25 mM Tris pH 7.5 buffer.
Purification of Agrin-Nterm
Dialyzed culture fluid was applied onto a Ni affinity column (Amersham Biosciences UK). The column was washed with 10 column volumes of 20 mM Tris-HCl buffer, pH 7.9 containing 500 mM NaCl and 5 mM imidazole, then with 5 column volumes of 20 mM Tris-HCl buffer, pH 7.9 containing 500 mM NaCl and 30 mM imidazole and the bound protein was eluted with 20 mM Tris-HCl buffer, pH 7.9 containing 300 mM imidazole (Figure 2). The eluted protein was desalted on a Sephadex G-25 column equilibrated with 100 mM ammonium bicarbonate, pH 8.0 buffer and lyophilized. Recombinant protein was further purified with AKTA purifier 10 System (GE Healthcare, Uppsala, Sweden) using a Superdex gel filtration column (HiLoad 10/300 Superdex 200 GL) equilibrated with 100 mM ammonium bicarbonate buffer, pH 8.0 (Figure 3). Fractions of 0.5 ml were collected, samples were analysed by SDS–PAGE and the fractions containing pure Agrin-Nterm were pooled and lyophilized. The average yield of purified protein was 1.0–1.5 mg per liter tissue culture fluid.
Protein analyses
The composition of protein samples was analysed by SDS–PAGE using 6–16% linear polyacrylamide gradient slab gels under both reducing and non-reducing conditions. The gels were stained with Coomassie Brilliant Blue G-250. On SDS-PAGE recombinant Agrin-Nterm appeared as a broad, high molecular smear (Mr>90 kDa) characteristic of proteoglycans. The calculated molecular mass of recombinant Agrin-Nterm is 88,054 Da; the difference of predicted and observed molecular mass of Agrin-Nterm is due to glycosylation at multiple sites in this part of agrin [16].
The concentration of recombinant protein was determined using the extinction coefficient of 45475 M−1 cm−1. The extinction coefficient was determined with ExPASy's ProtParam tool (http://us.expasy.org/tools/protparam.html).
N-terminal sequencing was performed on an Applied Biosystems 471A protein sequencer with an online ABI120A PTH Amino Acid Analyser. The N-terminal sequence of Agrin-Nterm was RSDVCRGMLCGF (the residues in bold underline correspond to residues 65–74 of rat agrin).
Surface plasmon resonance analysis
Surface plasmon resonance measurements were performed on a BIAcore X instrument (GE Healthcare, Stockholm, Sweden) essentially as described previously [17].
Recombinant human proteins (BMP2, BMP4, TGFβ1, TGFβ-sRII) were dissolved according to the instructions of the manufacturer (R&D Systems, Wiesbaden, Germany). The proteins were diluted in 50 mM sodium acetate buffer, pH 4.5 at a final concentration of 0.04 µg/ml (TGFβ1 and BMPs) and 50 µl of these solutions were injected with a 5 µl/min flow rate for 10 min on a CM5 sensor chip (Biacore AB, Uppsala, Sweden) activated by the amine coupling method according to the instructions of the manufacturer. ECD-BMPRIA-sensor chips were prepared in a similar way, except that the protein was dissolved in 50 mM sodium acetate, pH 4.2 ((Szláma, Kondás, Trexler and Patthy, manuscript submitted to JBC). For interaction measurements, 70 µl samples containing different concentrations of the analyte were injected on the sensor-chips at a flow rate of 20 µl/min, followed by wash with buffer at a flow rate of 20 µl/min.
Binding and washes were performed in 20 mM HEPES, 150 mM NaCl, 5 mM EDTA, 0.005% Tween 20, pH 7.5 buffer. Regeneration of the chip surface after each cycle was performed with injection of 40 µl 20 mM HEPES, 150 mM NaCl, 5 mM EDTA, 0.005% Tween 20, pH 7.5 buffer containing 8 M urea over the sensor chip. All experiments were repeated at least twice. Reference cells were used to obtain control sensorgrams showing non-specific binding to the surface as well as refractive index changes resulting from changes in bulk properties of the solution. Reference flow cells were prepared by executing the coupling reaction in the presence of coupling buffer alone. Reference sensorgrams were subtracted from sensorgrams obtained with immobilized ligand. To correct for differences between the reaction and reference surfaces we have also subtracted the average of sensorgrams obtained with blank running buffer injections.
The kinetic parameters (ka – association rate constant; kd – dissociation rate constant; KD = kd/ka – equilibrium dissociation constant) for each interaction were determined by globally fitting the experimental data with BIAevaluation software 4.1 and the closeness of the fits was characterized by the χ2 values. Only fits with χ2 values lower than 5% of the Rmax were accepted. Data were fitted to a model of 1∶1 Langmuir interaction.
In solution-competition assays, constant concentrations of growth factors were incubated with increasing concentrations of Agrin-Nterm in 20 mM HEPES, 150 mM NaCl, 5 mM EDTA, 0.005% Tween 20 pH 7.5 buffer for 30 min at room temperature prior to injection on chips with immobilized ECDs of growth factor receptors.
Cell culture
Mink lung epithelial cells and HepG2-BRA cells were cultured in DMEM supplemented with 10% FBS, penicillin (100 U/ml) streptomycin (100 µg/ml) and geneticin at a concentration of 200 µg/ml (MLEC-clone32) or 700 µg/ml (HEPG2-BRA) at 37°C, 5%CO2.
Reporter assays
TGFβ1 activity was measured with MLEC-clone32 cells, whereas the activities of BMP2 and BMP4 were monitored with HEPG2-BRA cells, using 96-well tissue culture dishes. In these reporter assays MLEC-clone32 cells (1.6×104 cells/well) or HEPG2-BRA cells (5×103 cells/well) were allowed to attach for 3 hours or 24 hours respectively, then the medium was changed to DMEM supplemented with 0.1% BSA, penicillin (100 U/ml) streptomycin (100 µg/ml) containing 16 pM TGFβ1, 250 pM BMP2 or 250 pM BMP4 preincubated for 30 minutes with different concentrations of Agrin-Nterm. Control experiments were performed similarly, except that no growth factor was added.
After incubation for 17 hours at 37°C, 5%CO2 the cells were lysed in 100 µl lysis buffer and the luciferase activity of the samples were determined using the firefly luciferase assay kit of Biotium on an Appliskan luminometer (Thermo Electron Corporation, MA, USA). The protein content of the samples was determined with the Bio-Rad protein assay (Biorad, USA) and the luciferase activity was normalized to the protein content of the wells.
Sequence retrieval and analysis
Protein sequences of vertebrate agrins were retrieved from the NCBI (http://www.ncbi.nlm.nih.gov/sites/entrez) and UniProt (http://www.uniprot.org/) websites and were used as queries in BLAST searches (http://blast.ncbi.nlm.nih.gov/Blast.cgi) of protein, nucleotide and genomic databases to identify agrin orthologs of invertebrate species. In these analyses we focused on species with completely sequenced genomes representing major groups of Metazoa: the Placozoan Trichoplax adhaerens (http://genome.jgi-psf.org/Triad1/Triad1.home.html), the Nematodes Caenorhabditis elegans and Caenorhabditis elegans, the Arthropods Drosophila melanogaster, Drosophila pseudoobscura, Apis mellifera, Tribolium castaneum), the Echinoderm Strongylocentrotus purpuratus and the Urochordate Ciona intestinalis.
Invertebrate proteins identified in these searches were considered to be orthologs of vertebrate agrins if they satisfied the following criteria: 1) in reciprocal searches of vertebrate sections of protein sequence databases they gave the lowest E-scores with agrins; 2) in reciprocal searches of vertebrate sections of protein sequence databases the individual constituent domains of the candidate sequences gave the lowest E-scores with agrins.
Accordingly, appropriate invertebrate taxonomic sections of databases were first queried with vertebrate agrin sequences to identify proteins that gave the lowest E-scores then the ten top-scoring sequences were used in reciprocal searches of vertebrate sections of protein sequence databases. Sequences that gave the lowest E-scores with agrins were subjected to protein domain analyses using Pfam 23.0 (http://pfam.sanger.ac.uk/) and PfamA domains were identified with the search strategy ‘global and local (merged)’ using an E-value cut-off of 1.0. Sequences that contained NtA-, follistatin-, laminin EGF-, SEA or laminin G-domains were retained for further analysis (note that in Pfam 23.0 follistatin domains are identified as Kazal_1 or Kazal_2 domains).
In the final step individual domains of candidate agrin sequences were used as query to test whether in BLAST searches of vertebrate sections of sequence databases they give the lowest E-scores with agrins. Invertebrate sequences that passed this test were considered to be true orthologs of vertebrate agrins.
Invertebrate agrin sequences were analysed by the Mispred Procedure [18], [19] to identify and correct possible errors in gene prediction. To correct errors of predicted sequences, the genomic regions encoding the candidate agrin sequences were reanalysed by GENSCAN (http://genes.mit.edu/GENSCAN.html), GenomeScan (http://genes.mit.edu/genomescan.html), Augustus (http://augustus.gobics.de/), Wise2 (http://www.ebi.ac.uk/Tools/Wise2/index.html) and predictions that corrected the error(s) identified by MisPred were selected.
The domain architectures of invertebrate agrins were compared with those of vertebrate agrins and the validity of deviations (e.g. presence/absence of domains) was checked using the consensus sequence procedure [20]. Regions with less significant PfamA matches (10−5<E value<10−2) or regions (>100 residues) with no significant PfamA hits were analyzed with the consensus sequence procedure [20] to decide whether they are significantly related to known domain families.
The results of these analyses are summarized in Table S1 and Figures S1, S2, S3, S4, S5, S6. Multiple alignments of the sequences of constituent domains of agrins were obtained with ClustalW [21]. The multiple alignments were shaded using Boxshade 3.0. Identical residues conserved in the majority of sequences were highlighted with black bakground, chemically similar residues were highlighted with grey background.
Results
Agrin binds BMP2, BMP4 and TGFβ1
Surface plasmon resonance analysis revealed that soluble Agrin-Nterm has affinity for immobilized BMP2, BMP4 and TGFβ1 (Figure 4). Evaluation of the sensorgrams has shown that the equilibrium dissociation constants for the interaction of Agrin-Nterm with immobilized TGFβ family members were: TGFβ1, KD = 5,15×10−8 M; BMP2, KD = 2,62×10−7 M; BMP4, KD = 2,57×10−7 M, respectively (Table 1). These relatively high affinities raised the possibility that the Agrin-growth factor interactions may have biological importance. To assess the biological relevance of these interactions we have studied the ability of Agrin-Nterm to block the binding of growth factors to their receptors using SPR in a solution-competition format as well as in luciferase reporter assays.
Table 1. Kinetic parameters of the interaction of Agrin-Nterm with different members of the TGFβ family.
Interacting proteins | KD (M) | ka (1/Ms) | kd (1/s) |
Agrin-Nterm – TGFβ1* | 5,15×10−8 | 3,34×103 | 1,72×10−4 |
Agrin-Nterm – BMP2* | 2,62×10−7 | 1,09×103 | 2,86×10−4 |
Agrin-Nterm – BMP4* | 2,57×10−7 | 1,61×103 | 4,12×10−4 |
The rate constants of the association and dissociation reactions and the equilibrium dissociation constants of the interactions were determined from surface plasmon resonance measurements with the BIAevaluation software 4.0.
*Proteins marked by an asterisk were immobilized on sensorchips.
Effect of Agrin-Nterm on binding of BMP2, BMP4 and TGFβ1 to the extracellular domains of their cognate receptors
As shown in Figure 5 preincubation of BMP2 (Figure 5A) or BMP4 (Figure 5B) with increasing concentrations of Agrin-Nterm efficiently decreased the recorded SPR responses and observed association rates, indicating that BMP2-Agrin-Nterm and BMP4-Agrin-Nterm complexes are formed and that these complexes are unable to bind to the ECD of the receptor protein, BMPR1A. Analysis of the data with the method of Nieba et al. [22] has revealed that Agrin-Nterm caused 50% decrease in the observed rate of association (kobs) of BMP2 and BMP4 to the ECD of BMPR1A at 12 nM and 345 nM, respectively. In the case of TGFβ1 (Figure 5C) Agrin-Nterm caused 50% decrease in the observed rate of association of TGFβ1 to the ECD of TGF-βsRII at ∼2 µM.
We wish to point out that there is disagreement between the affinities determined in SPR assays in which one of the interacting partners are immobilized (see Table 1) and the affinities determined in solution competition assay formats. Since standard determination of binding constants from on- and off-rates may not reproduce binding constants in solution [22], we assume that the conclusions drawn from the latter experiments have greater biological relevance.
To check whether the interaction of Agrin-Nterm with BMP2, BMP4 and TGFβ1 interferes with the signalling activities of these growth factors we studied the influence of Agrin-Nterm in reporter assays.
Effect of Agrin-Nterm on growth factor activity of BMP2, BMP4 and TGFβ1
As shown in Figure 6, Agrin-Nterm efficiently inhibited the activity of BMP2 (Figure 6A) and BMP4 (Figure 6B) in luciferase reporter assays, half maximal inhibition being achieved by ∼0.5 µM and ∼0.6 µM Agrin-Nterm, respectively.
In contrast with BMP2 and BMP4, in the case of TGFβ1 Agrin-Nterm was unable to cause inhibition even at the highest concentrations (1 µM) used; interestingly, Agrin-Nterm caused a slight increase in TGFβ1 activity (Figure 6C).
Evolutionary history of agrin
We have shown that true orthologs of vertebrate agrins are present in the genomes of Placozoa (Trichoplax adhaerens), nematodes (Caenorhabditis elegans, Caenorhabditis briggsae), some Arthropods (Apis mellifera, Tribolium castaneum), Echonoderms (Strongylocentrotus purpuratus) and Urochordates (Ciona intestinalis); see Table S1. Interestingly, no orthologs of agrin could be identified in the completely sequenced genomes of Drosophila melanogaster and Drosophila pseudobscura.
The fact that agrins are present in Trichoplax adhaerens as well as Nematodes and Arthropods indicates that the common ancestor of agrins appeared prior to the divergence of Placozoa and Bilateria. Comparison of the domain architectures of agrins of different groups of Metazoa (see Figure 1) suggests that the common ancestor of these agrins already had an N-terminal laminin binding domain, follistatin-domain(s), EGF domain(s) and laminin G domain(s). Tandem duplication of follistatin-domains, acquisiton of laminin EGF and SEA domains resulted in a domain organization characteristic of vertebrate agrins (see Figures 1 and Figures S1, S2, S3, S4, S5, S6).
Comparison of the sequences of invertebrate and vertebrate agrins have also shown that the sequence motifs essential for the AchR clustering activity of vertebrate agrins are highly conserved in vertebrate agrins, but are not conserved in invertebrate agrins (see Figure 1, Figure S7 and Figure S8), suggesting a major change in the biological function of agrin at the base of vertebrate evolution.
Similarly, the neurotrypsin cleavage sites, highly conserved in vertebrates [23] are not conserved in invertebrate agrins. The region containing the so called α neurotrypsin cleavage site of vertebrate agrins (Figure S9) has no equivalent in invertebrate agrins (see Figure 1). The β neurotrypsin cleavage site of vertebrate agrins is present in the C-terminal region, between the fourth EGF and the third LamininG domain (see Figure 1). Alignment of the eqivalent regions shows high conservation of the β neurotrypsin cleavage site only in vertebrates (Figure S8). It must be pointed out that lack of conservation of neurotrypsin cleavage sites in invertebrates is consistent with the fact that neurotrypsin is restricted to vertebrates [24]. These results thus suggest that the control of agrin's biological function(s) by neurotrypsin evolved only in vertebrates, in parallel with the evolution of agrin's AchR clustering activity.
Discussion
The N-terminal part of agrin binds members of TGFβ family
Our observation that agrin binds BMP2, BMP4 and TGFβ1 expands the list of follistatin-domain containing proteins that have affinity for TGFβ family members. Follistatin and the protein encoded by follistatin-related gene (FLRG) bind and inhibit activin and GDF8/myostatin [25]–[28]. These proteins show strong preferential binding for activin over other TGFβ family members, including TGFβ1, BMP4, BMP6, and BMP7 [29], [30]. The follistatin-domains of the multidomain proteins WFIKKN1 and WFIKKN2 appear to be specific for GDF8/myostatin and the closely related GDF11 [17], [31], whereas in the case of agrin the preferred ligands are BMP2, BMP4 and TGFβ1.
Proteins that bind growth factors may control their action in multiple ways: they may act as inhibitors if they prevent their association with cellular receptors, they may serve as a reservoir for growth factors, they may localize their action in the vicinity of the binding proteins. The interplay between these effects is determined by the affinity and concentrations of the various interacting partners. Accordingly, we suggest that binding of growth factors by vertebrate agrins may have multiple functions: agrin may serve as a reservoir of these growth factors, may localize their action and may also inhibit their growth promoting activity.
Implications of the agrin-growth factor interactions for the development of the neuromuscular junction and CNS synapses
Obviously, the growth factor-binding activity of agrin has relevance for its role in development and maintenance of the neuromuscular junction only if growth factors of the TGFβ family also have a role in the control of synaptogenesis. Although relatively little is known about the role of TGFβs in synaptogenesis in vertebrates, it is noteworthy that in Xenopus, Schwann cells were shown to promote synaptogenesis at the neuromuscular junction via TGFβ1 [32] and that in rats BMP2 has been implicated in the modulation of sympathetic neuron growth [33]. In view of our findings it seems plausible to assume that agrin – as a growth factor-binding protein – may influence these processes. Similarly, our findings may be relevant for the observation that the N-terminal half of agrin is involved in agrin's ability to inhibit neurite outgrowth [16], [34]; it seems possible that the N-terminal half of agrin binds and inhibits the growth promoting activity of growth factors thereby inhibiting further neurite outgrowth after synapses have been successfully established.
In the case of some invertebrates, there is clear evidence that signaling by TGFβ family members plays a pivotal role in formation of NMJ [35]. The best-characterized signaling pathway, defined in Drosophila, is triggered by Glass bottom boat (Gbb), an Arthropod protein related to BMPs of vertebrates. Gbb acts as a muscle-derived retrograde signal that activates the TGFβ-pathway presynaptically; this pathway includes the type II receptor Wishful thinking, type I receptors Thick veins and Saxophone. Mutations that block this pathway result in small synapses that are morphologically aberrant and severely impaired functionally.
Our results showing that the N-terminal part of agrin binds growth factors may be of particular interest in the context of the recently reported role of this region of agrin for the promotion of dendritic and axonal filopodia, which are considered as precursors of new synapses. Studies with cultured neurons and non-neuronal cells revealed that transmembrane anchored agrin promotes the formation of filopodial protrusions [3], [4], [7], [8] and localized the active region for this effect to the N-terminal part of agrin containing follistatin domains [4], [8]. It is tempting to speculate that the filopodia-promoting effect of the N-terminal part of agrin is mediated by growth factors that are bound in this region.
Our finding that the N-terminal part of agrin binds growth factors may also have important functional consequences for the cleavage of vertebrate agrins by neurotrypsin [23]. Cleavage of vertebrate agrin by neurotrypsin (see Figure 1) separates the C-terminal region (involved in AchR clustering at the NMJ and activity-dependent promotion of dendritic filopodia in the CNS) from the N-terminal moiety (inhibiting neurite outgrowth, promoting axonal and dendritic filopodia and shown here to be involved in growth factor binding). Divorcing the particular functions associated with these regions by activity-dependent proteolytic cleavage may shift the balance between distinct regulatory functions of agrin.
Non-neuronal tissues of vertebrates, such as muscle, heart, kidney also express agrin (isoforms inactive in AchR clustering) but very little is known about the function of agrin in these tissues. We suggest that these agrin isoforms may function as growth factor-binding proteins.
Our finding that the N-terminal part of agrin binds growth factors also has important implications for the biological role of agrin in invertebrates. Despite the ancient origin of agrin practically nothing is known about its function in invertebrates. The fact that the completely sequenced genomes of Drosophila melanogaster and Drosophila pseudoobscura lack agrin genes (although genomes of other Arthropods, such as Apis mellifera and Tribolium castaneum do have typical agrins) suggests that insect agrin is dispensable for the synaptogenetic process.
The recent conclusion that C. elegans agrin is not involved in synaptogenesis [36] also cautions that functions assigned to vertebrate agrins are not necessarily valid for invertebrate agrins. It is noteworthy in this respect that the sequence motifs of the agrin isoforms that are implicated in AchR-clustering activity are not found in invertebrate agrins although they are highly conserved in vertebrates (see Figure 1, Figure S7 and Figure S8). Similarly, the fact that neurotrypsin cleavage sites are missing from invertebrates (see Figure 1 and Figure S8) suggests that the control of agrin's biological function(s) by neurotrypsin evolved only in vertebrates, in parallel with the evolution of agrin's AchR clustering activity.
The fact that there is an agrin ortholog in the Placozoan Trichoplax adhaerens, a simple organism that does not have nerve and muscle cells [37], clearly suggests that ancient agrins had function(s) other than those characterized in vertebrate synaptogenesis. We suggest that agrin's biological function as a growth factor binding protein may be more ancient and more general than its involvement in synaptogenesis. It should be noted that Trichoplax adhaerens has multiple members of the TGFβ family and all essential components of the TGFβ signalling pathway are also present in the Trichoplax genome [37].
Supporting Information
Acknowledgments
The authors thank Professor Daniel Rifkin (New York University) for the generous gift of HepG2-BRA and MLEC-clone32 cells.
Footnotes
Competing Interests: The authors have declared that no competing interests exist.
Funding: This work was supported by grants 72125 and 75836 from the National Scientific Research Fund of Hungary. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
References
- 1.Bezakova G, Rüegg MA. New insights into the roles of agrin. Nature Rev Molec Cell Biol. 2003;4:295–308. doi: 10.1038/nrm1074. [DOI] [PubMed] [Google Scholar]
- 2.Kummer TT, Misgeld T, Sanes JR. Assembly of the postsynaptic membrane at the neuromuscular junction: paradigm lost. Curr Opin Neurobiol. 2006;16:74–82. doi: 10.1016/j.conb.2005.12.003. [DOI] [PubMed] [Google Scholar]
- 3.Annies M, Bittcher G, Ramseger R, Loschinger J, Woll S, et al. Clustering transmembrane-agrin induces filopodia-like processes on axons and dendrites. Mol Cell Neurosci. 2006;31:515–524. doi: 10.1016/j.mcn.2005.11.005. [DOI] [PubMed] [Google Scholar]
- 4.McCroskery S, Chaudhry A, Lin L, Daniels MP. Transmembrane agrin regulates filopodia in rat hippocampal neurons in culture. Mol Cell Neurosci. 2006;33:15–28. doi: 10.1016/j.mcn.2006.06.004. [DOI] [PubMed] [Google Scholar]
- 5.Ksiazek I, Burkhardt C, Lin S, Seddik R, Maj M. Synapse loss in cortex of agrin-deficient mice after genetic rescue of perinatal death. J Neurosci. 2007;27:7183–7195. doi: 10.1523/JNEUROSCI.1609-07.2007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Matsumoto-Miyai K, Sokolowska E, Zurlinden A, Gee CE, Luscher D, et al. Coincident pre- and postsynaptic activation induces dendritic filopodia via neurotrypsin-dependent agrin cleavage. Cell. 2009;136:1161–1171. doi: 10.1016/j.cell.2009.02.034. [DOI] [PubMed] [Google Scholar]
- 7.McCroskery S, Bailey A, Lin L, Daniels MP. Transmembrane agrin regulates dendritic filopodia and synapse formation in mature hippocampal neuron cultures. Neuroscience. 2009;163:168–179. doi: 10.1016/j.neuroscience.2009.06.012. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Porten E, Seliger B, Schneider VA, Woll S, Stangel D, et al. The process-inducing activity of transmembrane agrin requires follistatin-like domains. J Biol Chem. 2010;285:3114–3125. doi: 10.1074/jbc.M109.039420. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Patthy L, Nikolics K. Functions of agrin and agrin-related proteins. Trends Neurosci. 1993;16:76–81. doi: 10.1016/0166-2236(93)90021-d. [DOI] [PubMed] [Google Scholar]
- 10.Bork P, Patthy L. The SEA module: a new extracellular domain associated with O-glycosylation. Protein Sci. 1995;4:1421–1425. doi: 10.1002/pro.5560040716. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Zhang B, Luo S, Wang Q, Suzuki T, Xiong WC, et al. LRP4 serves as a coreceptor of agrin. Neuron. 2008;60:285–297. doi: 10.1016/j.neuron.2008.10.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Kim N, Stiegler AL, Cameron TO, Hallock PT, Gomez AM, et al. Lrp4 is a receptor for Agrin and forms a complex with MuSK. Cell. 2008;135:334–342. doi: 10.1016/j.cell.2008.10.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Scotton P, Bleckmann D, Stebler M, Sciandra F, Brancaccio A, et al. Activation of muscle-specific receptor tyrosine kinase and binding to dystroglycan are regulated by alternative mRNA splicing of agrin. J Biol Chem. 2006;281:36835–36845. doi: 10.1074/jbc.M607887200. [DOI] [PubMed] [Google Scholar]
- 14.Abe M, Harpel JG, Metz CN, Nunes I, Loskutoff DJ, et al. An assay for transforming growth factor-beta using cells transfected with a plasminogen activator inhibitor-1 promoter-luciferase construct. Anal Biochem. 1994;216:276–284. doi: 10.1006/abio.1994.1042. [DOI] [PubMed] [Google Scholar]
- 15.Zilberberg L, ten Dijke P, Sakai LY, Rifkin DB. A rapid and sensitive bioassay to measure bone morphogenetic protein activity. BMC Cell Biol. 2007;8:41. doi: 10.1186/1471-2121-8-41. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Baerwald-de la Torre K, Winzen U, Halfter W, Bixby JL. Glycosaminoglycan-dependent and -independent inhibition of neurite outgrowth by agrin. J Neurochem. 2004;90:50–61. doi: 10.1111/j.1471-4159.2004.02454.x. [DOI] [PubMed] [Google Scholar]
- 17.Kondás K, Szláma G, Trexler M, Patthy L. Both WFIKKN1 and WFIKKN2 have high affinity for growth and differentiation factors 8 and 11. J Biol Chem. 2008;283:23677–23684. doi: 10.1074/jbc.M803025200. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Nagy A, Hegyi H, Farkas K, Tordai H, Kozma E, et al. Identification and correction of abnormal, incomplete and mispredicted proteins in public databases. BMC Bioinformatics. 2008;9:353. doi: 10.1186/1471-2105-9-353. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Harrow J, Nagy A, Reymond A, Alioto T, Patthy L, et al. Identifying protein-coding genes in genomic sequences. Genome Biol. 2009;10:201. doi: 10.1186/gb-2009-10-1-201. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Patthy L. Detecting homology of distantly related proteins with consensus sequences. J Mol Biol. 1987;198:567–577. doi: 10.1016/0022-2836(87)90200-2. [DOI] [PubMed] [Google Scholar]
- 21.Larkin MA, Blackshields G, Brown NP, Chenna R, McGettigan PA, et al. Clustal W and Clustal X version 2.0. Bioinformatics. 2007;23:2947–2948. doi: 10.1093/bioinformatics/btm404. [DOI] [PubMed] [Google Scholar]
- 22.Nieba L, Krebber A, Plückthun A. Competition BIAcore for measuring true affinities: large differences from values determined from binding kinetics. Anal Biochem. 1996;234:155–165. doi: 10.1006/abio.1996.0067. [DOI] [PubMed] [Google Scholar]
- 23.Reif R, Sales S, Hettwer S, Dreier B, Gisler C, et al. Specific cleavage of agrin by neurotrypsin, a synaptic protease linked to mental retardation. FASEB J. 2007;21:3468–78. doi: 10.1096/fj.07-8800com. [DOI] [PubMed] [Google Scholar]
- 24.Sonderegger P, Patthy L. Comment on “Tequila, a neurotrypsin ortholog, regulates long-term memory formation in Drosophila”. Science. 2007;316:1698. doi: 10.1126/science.316.5832.1698a. [DOI] [PubMed] [Google Scholar]
- 25.Lee SJ, McPherron AC. Regulation of myostatin activity and muscle growth. Proc Natl Acad Sci U S A. 2001;98:9306–9311. doi: 10.1073/pnas.151270098. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Hill JJ, Davies MV, Pearson AA, Wang JH, Hewick RM, et al. The myostatin propeptide and the follistatin-related gene are inhibitory binding proteins of myostatin in normal serum. J Biol Chem. 2002;277:40735–40741. doi: 10.1074/jbc.M206379200. [DOI] [PubMed] [Google Scholar]
- 27.Nakamura T, Takio K, Eto Y, Shibai H, Titani K, et al. Activin-binding protein from rat ovary is follistatin. Science. 1990;247:836–838. doi: 10.1126/science.2106159. [DOI] [PubMed] [Google Scholar]
- 28.Tsuchida K, Arai KY, Kuramoto Y, Yamakawa N, Hasegawa Y, et al. Identification and characterization of a novel follistatin-like protein as a binding protein for the TGF-β family. J Biol Chem. 2000;275:40788–40796. doi: 10.1074/jbc.M006114200. [DOI] [PubMed] [Google Scholar]
- 29.Tortoriello DV, Sidis Y, Holtzman DA, Holmes WE, Schneyer AL. Human follistatin-related protein: a structural homologue of follistatin with nuclear localization. Endocrinology. 2001;142:3426–3434. doi: 10.1210/endo.142.8.8319. [DOI] [PubMed] [Google Scholar]
- 30.Sidis Y, Tortoriello DV, Holmes WE, Pan Y, Keutmann HT, et al. Follistatin-related protein and follistatin differentially neutralize endogenous vs. exogenous activin. Endocrinology. 2002;143:1613–1624. doi: 10.1210/endo.143.5.8805. [DOI] [PubMed] [Google Scholar]
- 31.Hill JJ, Qiu Y, Hewick RM, Wolfman NM. Regulation of myostatin in vivo by growth and differentiation factor-associated serum protein-1: a novel protein with protease inhibitor and follistatin domains. Mol Endocrinol. 2003;17:1144–1154. doi: 10.1210/me.2002-0366. [DOI] [PubMed] [Google Scholar]
- 32.Feng Z, Ko CP. Schwann cells promote synaptogenesis at the neuromuscular junction via transforming growth factor-beta1. J Neurosci. 2008;28:9599–9609. doi: 10.1523/JNEUROSCI.2589-08.2008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Moon JI, Birren SJ. Target-dependent inhibition of sympathetic neuron growth via modulation of a BMP signaling pathway. Dev Biol. 2008;315:404–417. doi: 10.1016/j.ydbio.2007.12.041. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Bixby JL, Baerwald-De la Torre K, Wang C, Rathjen FG, Rüegg MA. A neuronal inhibitory domain in the N-terminal half of agrin. J Neurobiol. 2002;50:164–179. doi: 10.1002/neu.10025. [DOI] [PubMed] [Google Scholar]
- 35.Wu H, Xiong WC, Mei L. To build a synapse: signaling pathways in neuromuscular junction assembly. Development. 2010;137:1017–1033. doi: 10.1242/dev.038711. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Hrus A, Lau G, Hutter H, Schenk S, Ferralli J, et al. C. elegans agrin is expressed in pharynx, IL1 neurons and distal tip cells and does not genetically interact with genes involved in synaptogenesis or muscle function. PLoS ONE. 2007;2:e731. doi: 10.1371/journal.pone.0000731. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Srivastava M, Begovic E, Chapman J, Putnam NH, Hellsten U, et al. The Trichoplax genome and the nature of placozoans. Nature. 2008;454:955–60. doi: 10.1038/nature07191. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.